Dr. Lal Pathlabs Ltd Share Price & Stock Analysis

Dr. Lal Pathlabs Ltd (NSE: LALPATHLAB, BSE: 539524) is a Gurugram, Haryana-based company in the Medical Diagnostic Centres industry. With a market capitalisation of ₹33,934 Cr, it ranks #259 by market cap among the 6,197 Indian listed companies on FinBizNet, and #1 of 18 in Medical Diagnostic Centres. At ₹1,983.30 (as of 16 Nov 2026), the share price is 4.6% below its 52-week high of ₹2,079.00 and 55.8% above its 52-week low of ₹1,272.60. The share price is up 28.7% over one year and up 1.2% over three months.

Key Metrics

Current Price₹1,983.30
Market Cap₹33,934 Cr
NSE SymbolLALPATHLAB
BSE Code539524
SectorHealth Care > Health Care Equipment and Services > Health Care Providers and Services
Sub-IndustryHealth Care Services > Medical Diagnostic Centres
P/E Ratio66.4
Return on Equity21.48%
Return on Assets13.34%
52-Week Range₹1,272.60 – ₹2,079.00
1-Year Price Change+28.7%
3-Month Price Change+1.2%
Beta (1Y)0.55
Dividend Yield1.00%
HeadquartersGurugram, Haryana
Websitewww.lalpathlabs.com

Latest Quarterly Results — Q2 FY27

Revenue₹874 Cr
Net Profit₹194 Cr
Net Margin22.2%
EPS (Basic)₹11.51
Basisconsolidated

Figures in ₹ crore, parsed from the company's exchange filing (XBRL).

Dr. Lal Pathlabs Ltd Quarterly Revenue and Profit Trend

Dr. Lal Pathlabs Ltd reported revenue of ₹874 Cr in Q2 FY27, up 19.6% from ₹731 Cr in Q2 FY26 and up 9.6% from ₹798 Cr in Q1 FY27. It posted a net profit of ₹194 Cr for the quarter, against a net profit of ₹152 Cr in Q2 FY26 (up 27.4%). Across the 7 quarters from Q4 FY25 to Q2 FY27, quarterly revenue ranged from ₹603 Cr (Q4 FY25) to ₹874 Cr (Q2 FY27). The company was profitable in each of these 7 quarters.

QuarterRevenueNet ProfitNet Margin
Q2 FY27₹874 Cr₹194 Cr22.2%
Q1 FY27₹798 Cr₹171 Cr21.4%
Q4 FY26₹703 Cr₹132 Cr18.8%
Q3 FY26₹660 Cr₹91 Cr13.9%
Q2 FY26₹731 Cr₹152 Cr20.8%
Q1 FY26₹670 Cr₹134 Cr20.0%
Q4 FY25₹603 Cr₹156 Cr25.8%

Consolidated figures (₹ crore, XBRL filings).

Shareholding and Delivery

Promoters held 52.93% of Dr. Lal Pathlabs Ltd's shares as of Sept 2026, against 53.21% in Sept 2025 (−0.28 percentage points). Delivery averaged 58.5% of traded volume across 16 NSE sessions (22 Oct 2026 – 13 Nov 2026).

About Dr. Lal Pathlabs Ltd

Dr. Lal PathLabs Limited operates laboratories for carrying out pathological investigations in India and internationally. The company provides pathological investigations of various branches of bio-chemistry, hematology, histopathology, microbiology, electrophoresis, immuno-chemistry, immunology, virology, cytology, and other pathological and radiological investigations. It also offers phlebotomist training programs. The company was founded in 1949 and is based in Gurugram, India.

Products and Services

1. Running Laboratories-This segment engages in running laboratories for carrying out pathological investigations of various branches of bio-chemistry, hematology, histopathology, microbiology, electrophoresis, immuno-chemistry, immunology, virology, cytology, and other pathological and radiological investigations.

Business Segments

1. Running Laboratories-100%

Dr. Lal Pathlabs Ltd vs Peers — Medical Diagnostic Centres

CompanyMarket CapP/EROELatest Qtr Revenue1Y Change
Dr. Lal Pathlabs Ltd₹33,934 Cr66.421.48%₹874 Cr+28.7%
Vijaya Diagnostic Centre Limited₹14,665 Cr84.319.70%₹255 Cr+38.5%
Metropolis Healthcare Limited₹11,952 Cr61.513.37%₹497 Cr+14.9%
Throcare Technologies Ltd₹7,764 Cr47.628.74%₹271 Cr+7.5%
SURAKSHA DIAGNOSTIC LIMITED₹1,856 Cr55.413.84%₹99 Cr+6.9%
Krsnaa Diagnostics Ltd₹1,625 Cr16.810.89%₹271 Cr-27.0%
Gaudium IVF and Women Health Limited₹803 Cr27.416.08%₹37 Cr—
Chandan Healthcare Limited₹582 Cr21.918.43%₹81 Cr—
Aspira Pathlab & Diagnostics Ltd₹127 Cr2,360——+115.2%

Listed by market capitalisation. Ratios are shown for context only.

Frequently Asked Questions

What is the current share price of Dr. Lal Pathlabs Ltd?

Dr. Lal Pathlabs Ltd is trading at ₹1,983.30, with a market capitalisation of ₹33,934 Cr.

Which sector does Dr. Lal Pathlabs Ltd belong to?

Dr. Lal Pathlabs Ltd operates in the Health Care > Health Care Equipment and Services > Health Care Providers and Services space (Health Care Services > Medical Diagnostic Centres).

What are the key financial ratios of Dr. Lal Pathlabs Ltd?

Dr. Lal Pathlabs Ltd has a P/E of 66.4 and a return on equity of 21.48%.

What is the stock symbol of Dr. Lal Pathlabs Ltd?

Dr. Lal Pathlabs Ltd is listed on the NSE under the symbol LALPATHLAB and on the BSE under the scrip code 539524.

How has Dr. Lal Pathlabs Ltd's share price moved over the past year?

Dr. Lal Pathlabs Ltd's share price is up 28.7% over one year and up 1.2% over three months. Its 52-week range is ₹1,272.60 to ₹2,079.00.

What were Dr. Lal Pathlabs Ltd's latest quarterly results?

In Q2 FY27, Dr. Lal Pathlabs Ltd reported revenue of ₹874 Cr and net profit of ₹194 Cr, with basic EPS of ₹11.51 (consolidated, parsed from the company's exchange filing).

How have Dr. Lal Pathlabs Ltd's revenue and profit changed over the past year?

Dr. Lal Pathlabs Ltd reported revenue of ₹874 Cr in Q2 FY27, up 19.6% from ₹731 Cr in Q2 FY26 and up 9.6% from ₹798 Cr in Q1 FY27.

What is the promoter holding in Dr. Lal Pathlabs Ltd?

Promoters held 52.93% of Dr. Lal Pathlabs Ltd's shares as of Sept 2026, against 53.21% in Sept 2025 (−0.28 percentage points).

More on FinBizNet

Data as of 16 Nov 2026. Descriptive market data only — not investment advice.